AIA Group Ltd Buys 2,737 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• AIA Group Ltd has increased its stake in Intuitive Surgical, Inc. to $10.53 million, owning 21,270 shares after acquiring an additional 2,737 shares in Q1.
• Insider sales included Gary S. Guthart and Myriam Curet, who sold significant portions of their holdings, with total insider sales amounting to approximately $7.92 million in the last quarter.
• Analysts have varied ratings on Intuitive Surgical, with a consensus rating of "Moderate Buy" and an average price target of $595.95, reflecting differing outlooks on stock performance.

AIA Group Ltd boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,270 shares of the medical equipment provider's stock after buying an additional 2,737 shares during the quarter. AIA Group Ltd's holdings in Intuitive Surgical were worth $10,534,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ISRG. Nuveen LLC bought a new stake in Intuitive Surgical during the 1st quarter worth about $1,715,899,000. GAMMA Investing LLC lifted its holdings in Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after buying an additional 3,022,979 shares during the period. Capital Research Global Investors lifted its holdings in Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after buying an additional 687,906 shares during the period. Goldman Sachs Group Inc. boosted its stake in Intuitive Surgical by 26.1% in the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock valued at $1,396,496,000 after acquiring an additional 584,375 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after acquiring an additional 494,496 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,881 shares of company stock worth $7,920,634. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded up $6.34 on Tuesday, reaching $478.19. The company had a trading volume of 1,529,402 shares, compared to its average volume of 2,211,435. The company's fifty day moving average is $513.42 and its 200-day moving average is $527.10. The firm has a market capitalization of $171.42 billion, a price-to-earnings ratio of 66.69, a price-to-earnings-growth ratio of 4.95 and a beta of 1.59. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.78 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent research reports. Robert W. Baird reduced their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Citigroup reiterated a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.